EUVIMEDEUVIMED entdecken
Open Access

Structure-guided design of nucleosome-inspired nanoparticles for overcoming pulmonary barriers in fibrotic lung gene therapy

Nan Kong iD, Dinghao Chen iD, Bihan Wu, Juan Liang iD, Ziao Zhou, Huanfen Lu, Yaoting Li iD, Peng Zhang iD, Huayang Liu, Huaimin Wang iD

Science Advances · 2025

DOI: 10.1126/sciadv.ady0952 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Nan Kong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, School of Science, Westlake University, 600 Dunyu Road, Hangzhou 310030, Zhejiang, China. Hauptthemen laut MEDLINE: Nanoparticles, Genetic Therapy, Pulmonary Fibrosis, Nucleosomes. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Treating pulmonary fibrosis (PF), a progressive and fatal lung disease, remains a great challenge. Here, we report a nucleosome-inspired peptide MNM designed to overcome mucus and cellular barriers, which achieved pulmonary si TGF- β 1 delivery efficiently for PF therapy. By mimicking histone-mediated DNA packaging, we engineered MNM with three functional modules: a histone-mimetic small interfering RNA (siRNA) binder, a membrane-penetrating domain, and a hydrophilic mucus-diffusing sequence. MNM integrates mucus penetration, cellular uptake, and endosomal escape into one platform, achieving highly efficient pulmonary siRNA delivery. MNM–si TGF- β 1 nanoparticles suppressed profibrotic gene expression and inflammation, which notably improved survival and reduced collagen deposition in aggressive PF models. This work establishes a biomimetic strategy to overcome complex biological barriers, advancing siRNA therapy for PF. Beyond si TGF- β 1 delivery for PF therapy, MNM’s modular design is adaptable to messenger RNA, circular RNA, and other nucleic acids, offering a transformative platform for precision nanomedicine in pulmonary and systemic diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesGenetic TherapyPulmonary FibrosisNucleosomesHumansRNA, Small InterferingAnimalsTransforming Growth Factor beta1MiceLungPeptides

Substanzen

RNA, Small InterferingNucleosomesTransforming Growth Factor beta1Peptides

Autor:innen und Institutionen

  • Department of Chemistry, School of Science, Westlake University, 600 Dunyu Road, Hangzhou 310030, Zhejiang, China.
  • State Key Laboratory of Gene Expression, School of Science, Westlake University, Hangzhou, Zhejiang, China.

ORCID-Profile: Nan Kong, Dinghao Chen, Juan Liang, Yaoting Li, Peng Zhang, Huaimin Wang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Kong, N., Chen, D., Wu, B., Liang, J., Zhou, Z., Lu, H., Li, Y., Zhang, P., Liu, H., & Wang, H. (2025). Structure-guided design of nucleosome-inspired nanoparticles for overcoming pulmonary barriers in fibrotic lung gene therapy. Science Advances. https://doi.org/10.1126/sciadv.ady0952

Vancouver

Kong N, Chen D, Wu B, Liang J, Zhou Z, Lu H, et al. Structure-guided design of nucleosome-inspired nanoparticles for overcoming pulmonary barriers in fibrotic lung gene therapy. Science Advances. 2025. doi:10.1126/sciadv.ady0952

BibTeX
@article{Kong2025,
  author = {Kong, Nan and Chen, Dinghao and Wu, Bihan and Liang, Juan and Zhou, Ziao and Lu, Huanfen and Li, Yaoting and Zhang, Peng and Liu, Huayang and Wang, Huaimin},
  title = {Structure-guided design of nucleosome-inspired nanoparticles for overcoming pulmonary barriers in fibrotic lung gene therapy},
  journal = {Science Advances},
  year = {2025},
  doi = {10.1126/sciadv.ady0952}
}
Kostenlos starten →